{"id":606170,"date":"2024-06-04T22:26:59","date_gmt":"2024-06-05T02:26:59","guid":{"rendered":"https:\/\/platohealth.ai\/holt-resignation-leaves-amarin-with-third-ceo-in-14-months\/"},"modified":"2024-06-05T04:42:04","modified_gmt":"2024-06-05T08:42:04","slug":"holt-resignation-leaves-amarin-with-third-ceo-in-14-months","status":"publish","type":"post","link":"https:\/\/platohealth.ai\/holt-resignation-leaves-amarin-with-third-ceo-in-14-months\/","title":{"rendered":"Holt resignation leaves Amarin with third CEO in 14 months","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"
ARTICLE | Management Tracks<\/p>\n
\n By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst<\/span><\/span>\n<\/p>\n June 5, 2024 2:26 AM UTC<\/p>\n<\/div>\n<\/div>\n<\/div>\n Patrick Holt has resigned <\/span>as president and CEO of Amarin Corp. plc<\/a><\/b> (NASDAQ:AMRN) to pursue other opportunities, setting up EVP and President of the U.S. business unit Aaron Berg to become the cardiovascular company\u2019s third CEO since March 2023, when Karim Mikhail departed amid a proxy battle with Sarissa Capital. Berg, a 12-year veteran of the company, led the company after Mikhail\u2019s departure on an interim basis. He was previously CEO of Essentialis Inc. Shares of Amarin fell 18% Tuesday to $0.70, giving the company a market cap of about $290 million.<\/p>\n The Foundation for the National Institutes of Health<\/a><\/b> awarded the 2024 Lurie Prize <\/span>in Biomedical Sciences to Howard Chang of Stanford University. Chang and his team uncovered the role of long non-coding RNA in gene regulation and its effect on diseases such as cancer and autoimmunity. Chang is a professor of cancer research, dermatology and genetics at Stanford and an investigator at Howard Hughes Medical Institute…<\/p>\n ARTICLE | Management Tracks Plus: FNIH awards Lurie Prize to Stanford\u2019s Chang, and updates from Tectonic and Contineum By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst June 5, 2024 2:26 AM UTC Patrick Holt has resigned as president and CEO of Amarin Corp. plc (NASDAQ:AMRN) to pursue other opportunities, setting up EVP and […]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":2,"featured_media":606174,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[50],"tags":[],"acf":[],"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/606170"}],"collection":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/comments?post=606170"}],"version-history":[{"count":1,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/606170\/revisions"}],"predecessor-version":[{"id":606173,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/posts\/606170\/revisions\/606173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media\/606174"}],"wp:attachment":[{"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/media?parent=606170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/categories?post=606170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/platohealth.ai\/wp-json\/wp\/v2\/tags?post=606170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}<\/span><\/div>\n
\n